Enhanc3D Genomics expands leadership team with the appointment of Hazel Jones as Chief Operating Officer Post author: Post published:November 6, 2023 Post category:uncategorized Enhanc3D Genomics today announced the appointment of Hazel Jones as Chief Operating Officer. You Might Also Like New biomaterial could redefine recovery from brain and central nervous system injuries January 10, 2025 Combination therapy of dapagliflozin and semaglutide shows superior efficacy in type 2 diabetes management January 3, 2024 The impact of poverty on child development September 17, 2024
New biomaterial could redefine recovery from brain and central nervous system injuries January 10, 2025
Combination therapy of dapagliflozin and semaglutide shows superior efficacy in type 2 diabetes management January 3, 2024